Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

The drugmaker evaluated a post-surgery Herceptin, Perjeta and chemotherapy regimen over ten years in its phase 3 APHINITY study of 4,804 patients. The regimen slashed the risk of death by 17% ...

Herceptin with chemotherapy improved OS and PFS in HER2-positive gastric cancers, but benefits decreased after chemotherapy regimen changes. Major pathological response rates were higher with ...

Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy. Treatment with Herceptin (trastuzumab) and Perjeta (pertuzumab) ...

KEYTRUDA is the first anti-PD-1/L1 therapy in combination with trastuzumab and chemotherapy to demonstrate a statistically significant improvement in OS in this patient population Results from the ...

You also can use them along with chemo or other treatments. Herceptin (trastuzumab) is one of these targeted medicines for breast cancer. It works against a protein called HER2 (also sometimes ...

In studies, people who used Herceptin with chemotherapy (traditional drugs used to treat cancer) were more likely to have mild side effects compared with people who used Herceptin alone.

Sources also note that it is the only platinum-based chemotherapy with Food and Drug Administration (FDA) approval to treat breast cancer. Trastuzumab is a monoclonal antibody that locks onto the ...

Cytotoxic chemotherapy is considered the standard of care for palliative treatment, and trastuzumab combined with platinum-based chemotherapy is considered frontline therapy for HER2-positive AGC.

“Now we are walking in to see even patients with advanced lung cancer and telling them, ‘No chemo,’” Dr. Vonderheide said. Preparing a dose of the targeted drug Herceptin in ...